Standard BioTools
(NASDAQ) SLGC
This security has been delisted. This page is retained for historical reference.
SLGC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowSLGC Financials
Key Financial Metrics (TTM)
Gross Margin
55.60%
Operating Margin
-179.96%
Net Income Margin
-111.77%
Return on Equity
-18.59%
Return on Capital
-31.11%
Return on Assets
-16.86%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$33.63M
Operating Income
-$153.85M
EBITDA
-$136.24M
Operating Cash Flow
-$125.37M
Capital Expenditure
$3.48M
Free Cash Flow
-$121.89M
Cash & ST Invst.
$453.81M
Total Debt
$2.76M
Standard BioTools Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$22.05M
-47.1%
Gross Profit
$10.41M
-65.3%
Gross Margin
47.23%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
451
N/A
Net Income
-$22.16M
+32.7%
EBITDA
-$18.18M
+50.9%
Quarterly Fundamentals
Total Cash
$453.81M
-19.9%
Total Debt
$2.76M
N/A
Accounts Receivable
$20.73M
-17.2%
Inventory
$13.88M
-24.9%
Long Term Debt
$2.76M
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-16.86%
N/A
Return on Invested Capital
-29.10%
N/A
Free Cash Flow
-$22.16M
+43.8%
Operating Cash Flow
-$21.37M
+39.0%